MedPath

Effect of COVID 19 on lymphocyte and eosinophil count

Not Applicable
Conditions
Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Registration Number
CTRI/2020/10/028422
Lead Sponsor
AIIMS Patna
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All adult (age group >18) COVID positive patients getting admitted in our hospital would be recruited for the study.

Exclusion Criteria

Pregnant patients, blood malignancies, hereditary eosinophilic syndrome, or any other condition that can affect eosinophil/ lymphocyte count

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate the relationship between blood cells parameters (EOS, lymphocyte, Lymphocyte/neutrophil ratio) and disease severity.Timepoint: 4 month
Secondary Outcome Measures
NameTimeMethod
2.To evaluate the correlation between blood cells parameters (circulating EOS, lymphocyte counts) and patientsâ?? outcome: death, improvement or deterioration in the condition of the patient to be reclassified into other group.Timepoint: 4 month
© Copyright 2025. All Rights Reserved by MedPath